Cargando…
Vaccine and Drug Ontology Studies (VDOS 2014)
The “Vaccine and Drug Ontology Studies” (VDOS) international workshop series focuses on vaccine- and drug-related ontology modeling and applications. Drugs and vaccines have been critical to prevent and treat human and animal diseases. Work in both (drugs and vaccines) areas is closely related - fro...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766598/ https://www.ncbi.nlm.nih.gov/pubmed/26918107 http://dx.doi.org/10.1186/s13326-015-0039-8 |
_version_ | 1782417692300410880 |
---|---|
author | Tao, Cui He, Yongqun Arabandi, Sivaram |
author_facet | Tao, Cui He, Yongqun Arabandi, Sivaram |
author_sort | Tao, Cui |
collection | PubMed |
description | The “Vaccine and Drug Ontology Studies” (VDOS) international workshop series focuses on vaccine- and drug-related ontology modeling and applications. Drugs and vaccines have been critical to prevent and treat human and animal diseases. Work in both (drugs and vaccines) areas is closely related - from preclinical research and development to manufacturing, clinical trials, government approval and regulation, and post-licensure usage surveillance and monitoring. Over the last decade, tremendous efforts have been made in the biomedical ontology community to ontologically represent various areas associated with vaccines and drugs – extending existing clinical terminology systems such as SNOMED, RxNorm, NDF-RT, and MedDRA, developing new models such as the Vaccine Ontology (VO) and Ontology of Adverse Events (OAE), vernacular medical terminologies such as the Consumer Health Vocabulary (CHV). The VDOS workshop series provides a platform for discussing innovative solutions as well as the challenges in the development and applications of biomedical ontologies for representing and analyzing drugs and vaccines, their administration, host immune responses, adverse events, and other related topics. The five full-length papers included in this 2014 thematic issue focus on two main themes: (i) General vaccine/drug-related ontology development and exploration, and (ii) Interaction and network-related ontology studies. |
format | Online Article Text |
id | pubmed-4766598 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47665982016-02-26 Vaccine and Drug Ontology Studies (VDOS 2014) Tao, Cui He, Yongqun Arabandi, Sivaram J Biomed Semantics Editorial The “Vaccine and Drug Ontology Studies” (VDOS) international workshop series focuses on vaccine- and drug-related ontology modeling and applications. Drugs and vaccines have been critical to prevent and treat human and animal diseases. Work in both (drugs and vaccines) areas is closely related - from preclinical research and development to manufacturing, clinical trials, government approval and regulation, and post-licensure usage surveillance and monitoring. Over the last decade, tremendous efforts have been made in the biomedical ontology community to ontologically represent various areas associated with vaccines and drugs – extending existing clinical terminology systems such as SNOMED, RxNorm, NDF-RT, and MedDRA, developing new models such as the Vaccine Ontology (VO) and Ontology of Adverse Events (OAE), vernacular medical terminologies such as the Consumer Health Vocabulary (CHV). The VDOS workshop series provides a platform for discussing innovative solutions as well as the challenges in the development and applications of biomedical ontologies for representing and analyzing drugs and vaccines, their administration, host immune responses, adverse events, and other related topics. The five full-length papers included in this 2014 thematic issue focus on two main themes: (i) General vaccine/drug-related ontology development and exploration, and (ii) Interaction and network-related ontology studies. BioMed Central 2016-02-25 /pmc/articles/PMC4766598/ /pubmed/26918107 http://dx.doi.org/10.1186/s13326-015-0039-8 Text en © Tao et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Editorial Tao, Cui He, Yongqun Arabandi, Sivaram Vaccine and Drug Ontology Studies (VDOS 2014) |
title | Vaccine and Drug Ontology Studies (VDOS 2014) |
title_full | Vaccine and Drug Ontology Studies (VDOS 2014) |
title_fullStr | Vaccine and Drug Ontology Studies (VDOS 2014) |
title_full_unstemmed | Vaccine and Drug Ontology Studies (VDOS 2014) |
title_short | Vaccine and Drug Ontology Studies (VDOS 2014) |
title_sort | vaccine and drug ontology studies (vdos 2014) |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766598/ https://www.ncbi.nlm.nih.gov/pubmed/26918107 http://dx.doi.org/10.1186/s13326-015-0039-8 |
work_keys_str_mv | AT taocui vaccineanddrugontologystudiesvdos2014 AT heyongqun vaccineanddrugontologystudiesvdos2014 AT arabandisivaram vaccineanddrugontologystudiesvdos2014 |